Thinking Allowed
medical / technology / education / art / flub
The future of biopharma
Shifts in how diseases are diagnosed and prevented, custom treatments, curative therapies, digital therapeutics, and precision intervention could upend current business models in biopharma.
Deloitte's Five forces to 2040
Prevention and early detection
Customized treatments - interventions for very small populations
Curative therapies - gene therapy
Digital therapeutics - complementing or replacing medications
Precision intervention - robotics, nanotechnology, or tissue engineering reducing medications
Prevention and early detection
Customized treatments - interventions for very small populations
Curative therapies - gene therapy
Digital therapeutics - complementing or replacing medications
Precision intervention - robotics, nanotechnology, or tissue engineering reducing medications
Source: www2.deloitte.com
deloitte biopharma therapeutics therapies treatments intervention complementing populationscurative
RSS feed